Literature DB >> 21293270

Epilepsy, antiepileptic drugs and suicidality.

Manny Bagary1.   

Abstract

PURPOSE OF REVIEW: The risk of suicide is thought be increased in epilepsy. Antiepileptic drugs (AEDs) remain the primary treatment. An FDA alert in 2008 raised concerns that AEDs may increase the risk of suicidal thoughts and behaviour. The risk profile for suicide in epilepsy is examined in the context of recent reports investigating the risk of suicide and the reported association between AEDs and risk of suicide. RECENT
FINDINGS: Following a diagnosis of epilepsy the risk of completed suicide is increased (standardized mortality ratio 2-3.5); although the causes remain poorly understood, co-morbid depression and the first 6 months after epilepsy surgery seem to be particular risk factors. The evidence for AEDs increasing risk for suicide remains mixed and is based on retrospective data.
SUMMARY: The identification of risk factors such as mood or anxiety disorders in patients with epilepsy should not delay AED treatment as the risks associated with seizures far outweigh the current research evidence for increased AED-related suicide risk. A pragmatic approach to clinical assessment and management is suggested. Prospective AED trials should include validated scales to systematically identify neuropsychiatric complications of AEDs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293270     DOI: 10.1097/WCO.0b013e328344533e

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  9 in total

Review 1.  [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2014-05-20

Review 2.  Practice Update: Review of Anticonvulsant Therapy.

Authors:  Derek J Chong; Andrew M Lerman
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

3.  Prevalence of suicide attempts and their risk factors in school-aged patients with epilepsy: a population-based study.

Authors:  Tomor Harnod; Cheng-Li Lin; Chia-Hung Kao
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-02       Impact factor: 4.785

Review 4.  Rhythm and blues: animal models of epilepsy and depression comorbidity.

Authors:  S Alisha Epps; David Weinshenker
Journal:  Biochem Pharmacol       Date:  2012-08-23       Impact factor: 5.858

5.  Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.

Authors:  Tingting Fu; Qingxia Kong; Huaqiang Sheng; Lingyun Gao
Journal:  Neural Plast       Date:  2016-01-27       Impact factor: 3.599

Review 6.  Animal models to improve our understanding and treatment of suicidal behavior.

Authors:  T D Gould; P Georgiou; L A Brenner; L Brundin; A Can; P Courtet; Z R Donaldson; Y Dwivedi; S Guillaume; I I Gottesman; S Kanekar; C A Lowry; P F Renshaw; D Rujescu; E G Smith; G Turecki; P Zanos; C A Zarate; P A Zunszain; T T Postolache
Journal:  Transl Psychiatry       Date:  2017-04-11       Impact factor: 6.222

7.  The role of physical and mental multimorbidity in suicidal thoughts and behaviours in a Scottish population cohort study.

Authors:  Katerina Kavalidouª; Daniel J Smith; Geoff Der; Rory C O'Connor
Journal:  BMC Psychiatry       Date:  2019-01-23       Impact factor: 3.630

8.  Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage.

Authors:  Arvind Singhal; Jack Ross; Olena Seminog; Keith Hawton; Michael J Goldacre
Journal:  J R Soc Med       Date:  2014-05       Impact factor: 5.344

9.  Epilepsy With Suicide: A Bibliometrics Study and Visualization Analysis via CiteSpace.

Authors:  Yi Guo; Zheng-Yan-Ran Xu; Meng-Ting Cai; Wen-Xin Gong; Chun-Hong Shen
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.